0 Items
Toll Free (US) - +1-866-598-1553
sales@precisionbusinessinsights.com
Albumin Market: Global Market Estimation, Size, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

Albumin Market: Global Market Estimation, Size, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00 – $ 8,900.00

Albumin Market by Type (Human Serum Albumin, Bovine Serum Albumin, and Recombinant Albumin), By Application (Drug Formulation and Vaccines, Life Sciences, Culture Media Ingredient, and Others), By Distribution Channel (Biopharmaceutical and Biotechnology Companies, Academic Research Institutes, and Others) and Geography

 

 

Request Sample Request Methodology
Request Sample Read More
$ PRICE - $ 3,000.00 – $ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00 – $ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:
Report

Description

Albumin Market size was valued at USD 6,1321 million in 2021, growing at a CAGR of 9.8% from 2022-28. Albumins belong to the family of globular proteins. All the proteins present in the albumin family are water-soluble and are moderately soluble in the concentrated salt solutions. When subjected to heat, undergo denaturation. The albumins contribute 50% to 60% of the blood plasma proteins. The most common of them is the serum albumins. The human serum albumin is the most abundant protein in human blood plasma. In March 2016, CSL Behring has announced that the U.S. Food and Drug Administration (FDA) has approved IDELVION [Coagulation Factor IX (Recombinant), Albumin Fusion Protein], its novel, long-acting albumin fusion protein linking recombinant coagulation factor IX with recombinant albumin for the treatment of hemophilia B. The global Albumin Market research report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezuela, and Rest of Latin America), and the Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of the Middle East and Africa).

Albumin Market

MARKET SUMMARY
-
9.8% CAGR
  • Study Period– 2022 – 2028
  • Base Year– 2021
  • CAGR– 9.8%
  • Largest Market– APAC
  • Fastest Growing Market– Europe

Albumin Market

  • The report on the global Albumin Market gives historical, current, and future market sizes (US$ Mn) based on the type, application, distribution channel and Geography.
  • Global Albumin Market gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Market Key Players
  • Thermo Fisher Scientific (U.S)
  • MedxBio Pte. Ltd. (Singapore)
  • China Biologic Products Inc. (China)
  • CSL Behring LLC (U.S)
  • Baxter International, Inc. (U.S)
  • Novozymes A/S. (Denmark)
Drivers And Restraints

Albumin Market

Increase in the prevalence of liver disease is the major driving factor for the growth of the market. The increasing instances of conditions such as trauma and shock are anticipated to drive market revenue growth over the forecast period. Growing use of the albumin in the form of an excipient in the drug delivery and increasing acceptance of the drug among the healthcare fraternity is expected to enhance the growth of the market over the forecast period. However, availability of alternative therapies, dearth of the plasma, and scarcity of blood donors are likely to hinder the growth of the market over the forecast period.

Asia Pacific got significant share

Albumin Market

Asia Pacificalbumin market is growing due to increase in the demand for albumin. The increasing patient population requiring albumin is anticipated to drive the growth of the albumin market in this region. The increasing awareness among the patient pool is likely to enhance the growth of the market in this region. Falling next to Asia Pacific are the regions of North America and Europe, which are expected to lose their share in the market owing to its preference for alternatives of albumin.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East
Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market and forecast.
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Segmentation

Albumin Market

segmentation-block-image

type

    • Human Serum Albumin
    • Bovine Serum Albumin
    • Recombinant Albumin
segmentation-block-image

application

    • Drug Formulation and Vaccines
    • Life Sciences
    • Culture Media Ingredient
    • Others
segmentation-block-image

Distribution Channel

    • Biopharmaceutical and Biotechnology companies
    • Academic research institutes
    • Others
segmentation-block-image

By Geography

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
Location

GEOGRAPHY

Frequently Asked Questions

The CAGR of the albumin market is 9.8% over the forecast period (2022 – 2028)

 

 

CSL Behring, Novozymes A/S, Thermo Fisher Scientific, Octapharma AG, MedxBio Pte. Ltd.

The Asia Pacific is the fastest-growing region for the albumin market

Report

Table Of Content

1. Executive Summary

2. Global Albumin Market Introduction

2.1. Global Albumin Market – Taxonomy

2.2. Global Albumin Market –Definitions

2.2.1. Type

2.2.2. Application

2.2.3. Distribution Channel

3. Global Albumin Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Albumin Market Dynamic Factors – Impact Analysis

3.6. Global Albumin Market – Competition Landscape

3.7. Epidemiology

4. Global Albumin Market Analysis,2015 – 2019 and Forecast, 2020 – 2026

4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market OpportunityAnalysis

5. Global Albumin Market, By Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

5.1. Human Serum Albumin

5.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Bovine Serum Albumin

5.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Recombinant Albumin

5.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

6. Global Albumin Market Forecast, By Application,2015 – 2019 and Forecast, 2019 – 2026

6.1. Drug Formulation and Vaccines

6.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Life Sciences

6.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Culture Media Ingredient

6.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Others

6.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

7. Global Albumin Market Forecast, By Distribution Channel, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

7.1. Biopharmaceutical and Biotechnology companies

7.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Academic research institutes

7.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Others

7.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

8. Global Albumin Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

8.1. North America

8.1.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Europe

8.2.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Asia-Pacific

8.3.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Latin America

8.4.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

8.5. Middle East and Africa

8.5.1. Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.5.3. Market Opportunity Analysis

8.6. Global Albumin Market – Opportunity Analysis Index, By Type, By Application, By Distribution Channel,and Region, 2020 – 2026

9. North America Albumin MarketAnalysis,2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

9.1. Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

9.1.1. Human Serum Albumin

9.1.2. Bovine Serum Albumin

9.1.3. Recombinant Albumin

9.2. Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

9.2.1. Drug Formulation and Vaccines

9.2.2. Life Sciences

9.2.3. Culture Media Ingredient

9.2.4. Others

9.3. Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

9.3.1. Biopharmaceutical and Biotechnology companies

9.3.2. Academic research institutes

9.3.3. Others

9.4. Country Analysis 2016 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

9.4.1. U.S.

9.4.2. Canada

9.5. North America Albumin Market – Opportunity Analysis Index, By Type, By Application, By Distribution Channel, and Country, 2020 – 2026

9.6. North America Albumin Market Dynamics – Trends

10. Europe Albumin Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

10.1. Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

10.1.1. Human Serum Albumin

10.1.2. Bovine Serum Albumin

10.1.3. Recombinant Albumin

10.2. Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.2.1. Drug Formulation and Vaccines

10.2.2. Life Sciences

10.2.3. Culture Media Ingredient

10.2.4. Others

10.3. Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

10.3.1. Biopharmaceutical and Biotechnology companies

10.3.2. Academic research institutes

10.3.3. Others

10.4. Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.4.1. Germany

10.4.2. UK

10.4.3. France

10.4.4. Spain

10.4.5. Italy

10.4.6. Russia

10.4.7. Poland

10.4.8. Rest of Europe

10.5. Europe Albumin Market – Opportunity Analysis Index, By Type, By Application, By Distribution Channel, and Country,2020 – 2026

10.6. Europe Albumin Market Dynamics – Trends

11. Asia-Pacific Albumin Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

11.1. Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

11.1.1. Human Serum Albumin

11.1.2. Bovine Serum Albumin

11.1.3. Recombinant Albumin

11.2. Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.2.1. Drug Formulation and Vaccines

11.2.2. Life Sciences

11.2.3. Culture Media Ingredient

11.2.4. Others

11.3. Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

11.3.1. Biopharmaceutical and Biotechnology companies

11.3.2. Academic research institutes

11.3.3. Others

11.4. Country Analysis2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.4.1. Japan

11.4.2. China

11.4.3. India

11.4.4. ASEAN

11.4.5. Australia & New Zealand

11.4.6. Rest of Asia-Pacific

11.5. Asia-Pacific Albumin Market – Opportunity Analysis Index, By Type, By Application, By Distribution Channel, and Country,2020 – 2026

11.6. Asia-Pacific Albumin Market Dynamics – Trends

12. Latin America Albumin Market Analysis,  2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

12.1. Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

12.1.1. Human Serum Albumin

12.1.2. Bovine Serum Albumin

12.1.3. Recombinant Albumin

12.2. Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.2.1. Drug Formulation and Vaccines

12.2.2. Life Sciences

12.2.3. Culture Media Ingredient

12.2.4. Others

12.3. Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

12.3.1. Biopharmaceutical and Biotechnology companies

12.3.2. Academic research institutes

12.3.3. Others

12.4. Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.4.1. Brazil

12.4.2. Mexico

12.4.3. Argentina

12.4.4. Venezuela

12.4.5. Rest of Latin America

12.5. Latin America Albumin Market – Opportunity Analysis Index, By Type, By Application, By Distribution Channel, and Country,2020 – 2026

12.6. Latin America Albumin Market Dynamics – Trends

13. Middle East and Africa Albumin Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

13.1. Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)

13.1.1. Human Serum Albumin

13.1.2. Bovine Serum Albumin

13.1.3. Recombinant Albumin

13.2. Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.2.1. Drug Formulation and Vaccines

13.2.2. Life Sciences

13.2.3. Culture Media Ingredient

13.2.4. Others

13.3. Distribution Channel Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)

13.3.1. Biopharmaceutical and Biotechnology companies

13.3.2. Academic research institutes

13.3.3. Others

13.4. Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

13.4.1. Gulf Cooperation Council (GCC) Countries

13.4.2. Israel

13.4.3. South Africa

13.4.4. Rest of MEA

13.5. MEA Albumin Market – Opportunity Analysis Index, By Type, ByApplication, By Distribution Channel, and Country,2020 – 2026

13.6. MEA Albumin Market Dynamics – Trends

14. Competition Landscape

14.1. Strategic Dashboard of Top Market Players

14.2. Company Profiles (Introduction, Financial Analysis, Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)

14.2.1. Thermo Fisher Scientific (U.S)

14.2.2. MedxBio Pte. Ltd. (Singapore)

14.2.3. China Biologic Products Inc. (China)

14.2.4. CSL Behring LLC (U.S)

14.2.5. Baxter International, Inc. (U.S)

14.2.6. Novozymes A/S. (Denmark)

14.2.7. Mitsubishi Tanabe Pharma (Japan)

14.2.8. Sigma-Aldrich Corporation (U.S)

14.2.9. Octapharma AG (Switzerland)

15. Research Methodology

16. Key Assumptions and Acronyms

Report

Company Profile

  • Thermo Fisher Scientific (U.S)
  • MedxBio Pte. Ltd. (Singapore)
  • China Biologic Products Inc. (China)
  • CSL Behring LLC (U.S)
  • Baxter International, Inc. (U.S)
  • Novozymes A/S. (Denmark)
  • Mitsubishi Tanabe Pharma (Japan)
  • Sigma-Aldrich Corporation (U.S)
  • Octapharma AG (Switzerland)

Description

Albumin Market size was valued at USD 6,1321 million in 2021, growing at a CAGR of 9.8% from 2022-28. Albumins belong to the family of globular proteins. All the proteins present in the albumin family are water-soluble and are moderately soluble in the concentrated salt solutions. When subjected to heat, undergo denaturation. The albumins contribute 50% to 60% of the blood plasma proteins. The most common of them is the serum albumins. The human serum albumin is the most abundant protein in human blood plasma. In March 2016, CSL Behring has announced that the U.S. Food and Drug Administration (FDA) has approved IDELVION [Coagulation Factor IX (Recombinant), Albumin Fusion Protein], its novel, long-acting albumin fusion protein linking recombinant coagulation factor IX with recombinant albumin for the treatment of hemophilia B. The global Albumin Market research report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland, and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezuela, and Rest of Latin America), and the Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of the Middle East and Africa).

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX

QUICKLINKS
RESEARCH AREAS
PRESS RELEASE
CONTACT US
+1-866-598-1553
EMAIL
sales@precisionbusinessinsights.com
FOLLOW US
QUICK LINKS+
RESEARCH AREAS+
PRESS RELEASE+
CONTACT US+
+1-866-598-1553
sales@precisionbusinessinsights.com
FOLLOW US AT+